Ibitta Enterprises Hires Consultant After GMP Inspection, Gets Warning Anyway
Executive Summary
Ibitta's response didn't provide sufficient documentation and other evidence indicating it will correct GMP problems found during FDA's May inspection. Warning also states some of firm's products are mis-branded, including stating information in two languages without repeating all required information in both languages.